In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton.
about
Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents3D-QSAR studies of latrunculin-based actin polymerization inhibitors using CoMFA and CoMSIA approaches.Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapyInhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies.A novel microtubule-modulating agent EM011 inhibits angiogenesis by repressing the HIF-1α axis and disrupting cell polarity and migrationSemisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: biological evaluations, preliminary structure-activity relationship and molecular modeling studies.Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine.The pharmacological bases of the antiangiogenic activity of paclitaxel.Interphase microtubules: chief casualties in the war on cancer?Amphiphilic suramin dissolves Matrigel, causing an 'inhibition' artefact within in vitro angiogenesis assays.
P2860
Q33841304-E108FAD9-8016-4C09-A1FB-2ABC241B6FCFQ34054363-1695E186-78A2-4B49-BA49-9926AC6E94B9Q34316618-846FD62B-832A-4D5B-A82D-D1F475162DA8Q36282749-7A68A110-20EA-4619-A22F-3B76FA31BDD3Q36447016-561C5AA5-A6B7-45B6-A06F-C3E9D4FF59A8Q36485483-C8758826-687B-4AED-986B-41C335BDD10DQ36629939-7AA6036E-7E51-4AE5-BC81-9935A313DE46Q36927558-4A7DD45B-2977-428D-984D-62181F844E1EQ38160670-C52D8716-CDA8-4CA3-88A3-D73E99BEC945Q46021445-368D3153-4F73-4C4A-A7BA-F600CAF8C16C
P2860
In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
In vitro pharmacological chara ...... ion of the actin cytoskeleton.
@en
In vitro pharmacological chara ...... ion of the actin cytoskeleton.
@nl
type
label
In vitro pharmacological chara ...... ion of the actin cytoskeleton.
@en
In vitro pharmacological chara ...... ion of the actin cytoskeleton.
@nl
prefLabel
In vitro pharmacological chara ...... ion of the actin cytoskeleton.
@en
In vitro pharmacological chara ...... ion of the actin cytoskeleton.
@nl
P2093
P1476
In vitro pharmacological chara ...... ion of the actin cytoskeleton.
@en
P2093
Caroline Hayot
Christine Decaestecker
Francis Darro
Marc Van Damme
Robert De Decker
Robert Kiss
Sophie Farinelle
P304
P577
2002-08-01T00:00:00Z